四川双马：公司以直投和投资孵化器平台的方式布局生物医药等科创领域

Core Viewpoint - Sichuan Shuangma is focusing on the biopharmaceutical sector, particularly in the innovation drug incubation area, utilizing direct investment and incubator platforms to enhance its portfolio in this field [2] Group 1: Company Strategy - The company is concentrating on the biopharmaceutical sector, specifically in innovative drug incubation [2] - Sichuan Shuangma has established a number of early-stage innovative drug enterprises with internationally competitive product data across various disease areas, including tumors, autoimmune diseases, metabolic disorders, and neurological diseases [2] - The company employs a systematic and platform-based incubation model to promote the transformation of research outcomes [2]